HomeCompareACMC vs ABBV

ACMC vs ABBV: Dividend Comparison 2026

ACMC yields 11230.00% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACMC wins by $37041.05M in total portfolio value
10 years
ACMC
ACMC
● Live price
11230.00%
Share price
$0.04
Annual div
$4.49
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37041.15M
Annual income
$1,955,985,185.58
Full ACMC calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — ACMC vs ABBV

📍 ACMC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACMCABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACMC + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACMC pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACMC
Annual income on $10K today (after 15% tax)
$954,550.00/yr
After 10yr DRIP, annual income (after tax)
$1,662,587,407.74/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, ACMC beats the other by $1,662,566,351.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACMC + ABBV for your $10,000?

ACMC: 50%ABBV: 50%
100% ABBV50/50100% ACMC
Portfolio after 10yr
$18520.63M
Annual income
$978,004,978.67/yr
Blended yield
5.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

ACMC
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACMC buys
0
ABBV buys
7
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-11-13
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-31
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-30
Lisa McClain🏢 House$ABBV▲ Buy$1,001 - $15,0002025-10-30
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-08-14
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACMCABBV
Forward yield11230.00%3.06%
Annual dividend / share$4.49$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%40.6%
Portfolio after 10y$37041.15M$102.3K
Annual income after 10y$1,955,985,185.58$24,771.77
Total dividends collected$30053.82M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACMC vs ABBV ($10,000, DRIP)

YearACMC PortfolioACMC Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$572,200$561,500.00$11,550$430.00+$560.6KACMC
2$15,625,819$15,013,565.42$13,472$627.96+$15.61MACMC
3$208,306,176$191,586,549.15$15,906$926.08+$208.29MACMC
4$1,416,355,080$1,193,467,471.98$19,071$1,382.55+$1416.34MACMC
5$5,307,486,692$3,791,986,755.92$23,302$2,095.81+$5307.46MACMC
6$12,319,037,185$6,640,026,425.12$29,150$3,237.93+$12319.01MACMC
7$20,383,216,720$7,201,846,932.21$37,536$5,121.41+$20383.18MACMC
8$27,378,386,045$5,568,344,154.09$50,079$8,338.38+$27378.34MACMC
9$32,789,874,972$3,495,001,904.28$69,753$14,065.80+$32789.81MACMC
10$37,041,151,406$1,955,985,185.58$102,337$24,771.77+$37041.05MACMC

ACMC vs ABBV: Complete Analysis 2026

ACMCStock

American Church Mortgage Company, a real estate investment trust, provides mortgage loans to churches and other non-profit religious organizations in the United States. It also selects and invests in mortgage-secured debt instruments issued by churches and other non-profit religious organizations. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. American Church Mortgage Company was founded in 1987 and is based in Minnetonka, Minnesota.

Full ACMC Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this ACMC vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACMC vs SCHDACMC vs JEPIACMC vs OACMC vs KOACMC vs MAINACMC vs JNJACMC vs MRKACMC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.